SF1126 Completed Phase 1 Trials for Cancer / Advanced or Metastatic Solid Tumor / Solid Cancers Treatment
Indications | Status | Purpose | Phase |
---|---|---|---|
Completed | Treatment | 1 |
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT00907205 | A Dose Escalation Study of SF1126, a PI3 Kinase (PI3K) Inhibitor, Given By Intravenous (IV) Infusion in Patients With Solid Tumors |